Friedman, Adam A.
Letai, Anthony
Fisher, David E.
Flaherty, Keith T.
Article History
First Online: 5 November 2015
Change Date: 10 November 2015
Change Type: Correction
Change Details: The sentence in Box 1 referring to non-synonymous mutations should have referred to synonymous mutations. This has been corrected to state "Even synonymous mutations can have effects on cellular fitness<sup>100</sup>."
Competing interests
: A.L. is a co-inventor on patents related to BH3 profiling for the selection of therapies for patients with cancer. A.A.F., A.L., D.E.F. and K.T.F. hold equity in and serve on the Scientific Advisory Board of Leap Oncology.